Kidney cancer in 2010: drugs, surgery and survival in RCC. - Wikidata - awgldk - TriplyDB

Kidney cancer in 2010: drugs, surgery and survival in RCC.

Kidney cancer in 2010: drugs, surgery and survival in RCC.

http://www.wikidata.org/entity/Q37838249

about

IgG is involved in the migration and invasion of clear cell renal cell carcinoma.CMTM3 is frequently reduced in clear cell renal cell carcinoma and exhibits tumor suppressor activities.Epigenetic silencing of ASPP1 confers 5-FU resistance in clear cell renal cell carcinoma by preventing p53 activation.

P2860

Q36968880-85BC6832-DD11-420C-A4C4-579D38C502E3 Q45143541-23BBF162-C72F-46D0-AE3C-BC7BA8CE5FD8 Q47979679-9561F1FB-543D-42DD-905B-63CD9896050D

P2860

Kidney cancer in 2010: drugs, surgery and survival in RCC.

http://www.wikidata.org/entity/Q37838249

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on February 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Kidney cancer in 2010: drugs, surgery and survival in RCC.

@en

Kidney cancer in 2010: drugs, surgery and survival in RCC.

@nl

type

label

Kidney cancer in 2010: drugs, surgery and survival in RCC.

@en

Kidney cancer in 2010: drugs, surgery and survival in RCC.

@nl

prefLabel

Kidney cancer in 2010: drugs, surgery and survival in RCC.

@en

Kidney cancer in 2010: drugs, surgery and survival in RCC.

@nl

P1433

Q37838249-6BC81F9C-7286-446A-B6CD-86845183A646

P1476

Q37838249-89E3609F-9EA7-48D2-BD84-7442CDD4963F

P2093

Q37838249-54C4D4FB-180C-4C59-9916-471262F7271C

P2860

Q37838249-215F6EC0-B76D-483E-B449-6CBBB048DEA2

Q37838249-36B6AF6E-4F24-426B-B103-89D39ADF8435

Q37838249-5D9B3582-751A-40CB-B16B-C3C468C248E6

Q37838249-C296BE77-F1FD-4352-8739-CD1E540E1591

Q37838249-C82F3891-A8B0-401A-B396-B54B83840FED

Q37838249-FB7675C5-909E-44FB-BDE9-7B1E224096F8

P2888

Q37838249-B8D86F38-3B5E-4C19-B62E-49D539807A58

P304

Q37838249-14CFC322-CF9C-4B6F-A958-19A138375A74

P31

Q37838249-B0E5516E-187F-4BFC-B5E8-B4FEE6B626A6

P356

Q37838249-92B662E4-DDD7-4EC2-A168-FE0B5936579C

P407

Q37838249-A3777960-6B03-400C-8953-9C7DD09CC7BD

P433

Q37838249-1B0F404C-AFD3-48F7-85D0-45910205B822

P478

Q37838249-539051BA-09E3-475E-BE6F-7B2C93DF159E

P50

Q37838249-B2D26C05-CD62-401C-9341-6ABC503D4F71

P577

Q37838249-852D923B-2EFF-4C7C-BC7A-EC8FBC045CA9

P698

Q37838249-26EE397A-114C-4CF4-BCED-E86665275F1C

P356

NRUROL.2010.228

P1433

Nature Reviews Urology

P1476

Kidney cancer in 2010: drugs, surgery and survival in RCC.

@en

P2093

Karim Bensalah

http://www.w3.org/2001/XMLSchema#string

P2860

Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trial

Evaluating overall survival and competing risks of death in patients with localized renal cell carcinoma using a comprehensive nomogram

Nephrectomy induced chronic renal insufficiency is associated with increased risk of cardiovascular death and death from any cause in patients with localized cT1b renal masses.

The natural history of observed enhancing renal masses: meta-analysis and review of the world literature.

Positive surgical margins at partial nephrectomy: predictors and oncological outcomes.

Tumor size and nephron-sparing surgery: does it still matter?

P2888

nrurol.2010.228

P304

66-68

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRUROL.2010.228

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Jean-Jacques Patard

P577

2011-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21304541

http://www.w3.org/2001/XMLSchema#string